Viridian Partners with Japanese Firm to Compete with Amgen’s Tepezza
Viridian Therapeutics has secured a licensing agreement with a Japanese pharmaceutical company as part of its strategy to compete with Amgen’s Tepezza. This partnership marks a significant milestone for Viridian,…